The Arcview Group

The Future of Psychedelic Medicine Investment

Join us for a free webinar to discuss psychedelic medicine investment!

  • 10:00 AM PT – Investing in Psychedelics – Arcview Capital & The Conscious Fund.
  • 10:30 AM PT – Last Mile of Medical Psychedelics – Albert Labs & Microdose
  • 11:00 AM PT – The Opportunities And The Science Behind The Psychedelic Renaissance – EI Ventures
  • 11:30 AM PT – Second Generation Psychedelics: enabling streamlined patient access to psychedelic therapeutics – BetterLife Pharma (BETR)
  • noon PT – Truths and Myths – Regulating the Psychedelic Landscape – Zuber Lawler

Register Now

Share this webinar:

Facebook
Twitter
LinkedIn
Email

Whether you’re just getting started, needing to make key connections or ready to raise your next round, Arcview has you covered with the right program for you.

The Arcview Group

The Arcview Group is a vertically integrated company servicing the cannabis and hemp industry, built with social justice and responsibility at its core. Arcview has been a trusted global leader for over ten years and nexus for investors, companies, entrepreneurs, and community, providing a broad spectrum of programs and services.

© 2023 The Arcview Group. All rights reserved.

WHY ARCVIEW

JOIN OUR MAILING LIST

Arcview Capital

Please be advised you are leaving the Arcview Group domain.